Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie M Randall

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|March 27, 2016
The genetic prediction of risk for gynecologic cancersLeslie M Randall, Bhavana Pothuri
Journal of Pediatric and Adolescent Gynecology|September 28, 2010
Malignant mixed ovarian germ cell tumor with embryonal componentNatalie Catharine Moniaga, Leslie M Randall
Gynecologic Oncology|April 6, 2010
Bevacizumab toxicities and their management in ovarian cancerLeslie M Randall, Bradley J Monk
Gynecologic Oncology Reports|February 7, 2019
Rapid progression of disease in two cases of undifferentiated endometrial carcinomaKrista S Pfaendler, Leslie M Randall
Biologics : Targets & Therapy|March 9, 2011
Bevacizumab in the treatment of ovarian cancerRamez N Eskander, Leslie M Randall
Gynecologic Oncology Case Reports|December 28, 2013
Uterine leiomyomatosis with intracaval and intracardiac extensionNatalie C Moniaga, Leslie M Randall
Expert Opinion on Pharmacotherapy|January 30, 2007
Topotecan in the management of cervical cancerLeslie M Randall-Whitis, Bradley J Monk
Cancer|April 23, 2024
Top advances of the year: Cervical cancerLinda R Duska, Sarah E Podwika, Leslie M Randall
The Oncologist|March 22, 2019
Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing PracticeLeslie M Randall, Michael J Birrer, Thomas J Herzog
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian CancerBradley J Monk, Leslie M Randall, Rachel N Grisham
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|March 27, 2016
The genetic prediction of risk for gynecologic cancersLeslie M Randall, Bhavana Pothuri
Journal of Pediatric and Adolescent Gynecology|September 28, 2010
Malignant mixed ovarian germ cell tumor with embryonal componentNatalie Catharine Moniaga, Leslie M Randall
Gynecologic Oncology|April 6, 2010
Bevacizumab toxicities and their management in ovarian cancerLeslie M Randall, Bradley J Monk
Gynecologic Oncology Reports|February 7, 2019
Rapid progression of disease in two cases of undifferentiated endometrial carcinomaKrista S Pfaendler, Leslie M Randall
Biologics : Targets & Therapy|March 9, 2011
Bevacizumab in the treatment of ovarian cancerRamez N Eskander, Leslie M Randall
Gynecologic Oncology Case Reports|December 28, 2013
Uterine leiomyomatosis with intracaval and intracardiac extensionNatalie C Moniaga, Leslie M Randall
Expert Opinion on Pharmacotherapy|January 30, 2007
Topotecan in the management of cervical cancerLeslie M Randall-Whitis, Bradley J Monk
Cancer|April 23, 2024
Top advances of the year: Cervical cancerLinda R Duska, Sarah E Podwika, Leslie M Randall
The Oncologist|March 22, 2019
Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing PracticeLeslie M Randall, Michael J Birrer, Thomas J Herzog
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian CancerBradley J Monk, Leslie M Randall, Rachel N Grisham
Pageof 6